Company / Cash & Equivalents
SS Innovations International, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$3.2M
FY2025
5-year range
$405.8K / $3.2M
FY2021-FY2025
Trend
+587.3%
vs FY2024
Sector context
#148 of 148
Health Care
What the data says
Cash & Equivalents changed +587% YoY in FY2025, a notable deviation from the 9-year average annual change of +156%.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +82.0%.
Improved from $2M to $3M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +28.7%
- 5-Year CAGR
- +82.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 148This company $3.2M Sector average $1.2B
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +82.0%, indicating consistent growth.
- In FY2025, cash & equivalents increased 587.3% year-over-year.
- Ranks #148 out of 148 companies in the Health Care sector.
- Lowest cash & equivalents in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2M | +587.3% |
| FY2024 | $466.5K | -76.9% |
| FY2023 | $2.0M | +34.5% |
| FY2022 | $1.5M | +270.7% |
| FY2021 | $405.8K | +152.5% |
| FY2020 | $160.7K | +464.4% |
| FY2019 | $28.5K | -20.3% |
| FY2018 | $35.7K | -92.1% |
| FY2017 | $452.6K | +82.3% |
| FY2016 | $248.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026